H21.23
Degeneration of iris (pigmentary)
Clinical Classification Guidelines
Inclusion Terms
- Translucency of iris
Medical Intelligence & Overview
Degeneration of the iris, specifically pigmentary degeneration, is a condition characterized by the gradual loss of pigment and transparency of the iris, the colored part of the eye. This process can lead to changes in eye appearance and vision. Its progression may influence how light enters the eye and can be associated with other eye conditions. Recognizing the signs and understanding the nature of this degeneration can help in managing eye health.
Causes & Symptoms
Clinical Causes: Aging-related changes in eye tissues Genetic predisposition or hereditary factors Chronic eye inflammation Certain eye diseases such as pigment dispersion syndrome Trauma or injury to the eye Underlying systemic conditions affecting connective tissues Environmental factors, such as prolonged exposure to UV light
Key Symptoms: Translucency or increased transparency of the iris Changes in iris pigmentation, leading to a lighter or more washed-out appearance Possible sensitivity to bright light (photophobia) Altered eye color perception In some cases, visual disturbances or blurriness Absence of pain or noticeable discomfort in early stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough eye examination by an ophthalmologist, including slit-lamp biomicroscopy to observe features such as iris translucency and pigmentation changes. Additional diagnostic tools, such as ocular imaging, may be used to evaluate the extent of degeneration. An eye history and possibly genetic testing could assist in understanding underlying causes or related conditions.
Treatment Protocols: Currently, there is no specific medical treatment to reverse pigmentary degeneration of the iris. Management focuses on monitoring eye health, addressing associated symptoms, and preventing complications. Regular eye examinations are essential for tracking changes over time. In cases where pigment dispersion contributes to other conditions like glaucoma, appropriate treatments, including medication or surgery, may be necessary. Protecting the eyes from further injury and UV exposure can also be beneficial.
Clinical Advice & FAQs
Billing Guidance
Is H21.23 a billable ICD-10 code?
Yes, H21.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H21.23?
Clinical documentation must specify the nature of Degeneration of iris (pigmentary) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference